Tech Company Financing Transactions
Forma Therapeutics Funding Round
On 12/1/2009, Forma Therapeutics secured $25.5 million in Series B financing from Lilly Ventures, Edbi and Novartis Venture Fund.
Transaction Overview
Company Name
Announced On
12/1/2009
Transaction Type
Venture Equity
Amount
$25,500,000
Round
Series B
Investors
Proceeds Purpose
"With this new funding, FORMA will focus on advancing our internal target-based oncology programs and in parallel, we will continue to pursue non-dilutive collaborations to further build our integrated drug discovery platform," said Steven Tregay, CEO of FORMA.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Arsenal St. 100
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology and other genetically driven therapeutic areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Lee
Chief Financial Officer
Todd Shegog
Chief Medical Officer
Patrick Kelly
Vice President
Paul Ehrlich
Vice President
Brian Lesser
Vice President
Jonathan O'Connell
VP - Bus. Development
Scott Boyle
VP - General Counsel
Jeannette Potts
VP - Human Resources
Mary Wadlinger
VP - Manufacturing
Suresh Babu
VP - R & D
Frances Duffy-Warren
Browse more venture capital transactions:
Prev: 12/1/2009: Aquantia venture capital transaction
Next: 12/2/2009: Vizu venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs